SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-010735
Filing Date
2021-01-19
Accepted
2021-01-19 06:21:53
Documents
12
Period of Report
2021-01-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d27901d8k.htm   iXBRL 8-K 29366
  Complete submission text file 0001193125-21-010735.txt   156754

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tcrr-20210119.xsd EX-101.SCH 3058
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrr-20210119_lab.xml EX-101.LAB 18888
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrr-20210119_pre.xml EX-101.PRE 11852
5 EXTRACTED XBRL INSTANCE DOCUMENT d27901d8k_htm.xml XML 3450
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38811 | Film No.: 21533788
SIC: 2836 Biological Products, (No Diagnostic Substances)